- Prevention / Eye Care
- Treatment
Antibiotic eye drops are used to treat or prevent the infection of eye and eye related infections. Many types bacteria causes the eye infections and most commonly caused eye infection is conjunctivitis. Different types of eye drops are used to treat the different types of eye infections. Broad spectrum antibiotics are primary choice for the bacterial eye infections and may be given in combinations or individually.
Global Antibiotic Eye Drops Market Summary
Study Period
2023-29
Base Year
2022
CAGR
x%
Largest Market
Asia-Pacific
Fastest Growing Market
North-America
Antibiotic Eye Drops Market
Factors such as increase in prevalence of the eye related infections such as conjunctivitis and rise in geriatric population globally expected drive the market growth over the forecast period. In addition, increase in R&D to develop the new antibiotic eye drops, rise in awareness about the infection among the people and advancements in the diagnostic techniques projected to bolster the market growth in near future. Moreover, increase in antibiotic resistance ocular infections creating the demand for new antibiotic eye drop products in the market. However, high cost of product development and maintenance of aseptic conditions for eye drops are expected to hamper the market growth over the forecast period.
North-America got Significant Share
Antibiotic Eye Drops Market
Geographically, global antibiotic eye drops Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America antibiotic eye drops market projected to have the significant growth rate owing to the high incidence rates of bacterial conjunctivitis in the region. According to a recent survey published in the JAMA (Journal of the American Medical Association) over 50% of the conjunctivitis in U.S. are bacterial origin. Furthermore, presence of the key market players, recent product launches expected to boost the regional market growth over the forecast period. Europe bacterial conjunctivitis market expected to grow at notable rates owing to the presence increase in incidence of bacterial eye infections and rise in awareness. Furthermore, market players are adopting strategies such as collaborations and acquisitions to expand the market position. For instance, in December 2017, NTC Pharma and Santen Pharmaceutical Co., Ltd. has entered into commercialization agreement in which Saten Pharmaceutical Co.Ltd., brought the distribution rights of NTC Pharma R&D products aimed for treating eye related diseases. Asia Pacific antibiotic eye drops market expected to have lucrative growth opportunity due to the significant development in medical infrastructure especially in developing countries such as India and China. Furthermore, low cost of production, huge and patient base attracting the multinational players to expand into Asia Pacific region.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Global Antibiotic Eye Drops Market Segmentation
purpose
antibiotic type
- Bactericidal Drops
- Bacteriostatic Drops
- Combination Drops
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Frequently Asked Questions
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
- Bausch + Lomb (U.S.)
- Abbott Laboratories (U.S.)
- Alcon (U.S.)
- Allergan plc (Ireland)
- Rohto Pharmaceutical Co., Ltd. (Japan)
- Similasan AG (Switzerladn)